Endocrine Flashcards
What are the treatment strategies for Diabetes Mellitus Type 1?
Low-sugar diet, insulin replacement
What are the treatment strategies for Diabetes Mellitus Type 2?
Dietary modification and exercise for weight loss; oral agents, non-insulin injectables, insulin replacement
Diabetes Drugs - What are the treatment strategies for Gestational Diabetes Mellitus?
Dietary modifications, exercise, insulin replacement if lifestyle modification fails
Diabetes Drugs - What is the mechanism of the rapid acting Insulin drugs (Lispro, Aspart, Glulisine)?
Bind insulin receptor (tyrosine kinase activity).
Liver: ↑ glucose stored as glycogen.
Muscle: ↑ glycogen, protein synthesis; ↑ K+ uptake.
Fat: ↑ TG storage.
Diabetes Drugs - What is the clinical use of the rapid acting Insulin drugs (Lispro, Aspart, Glulisine)?
DM1, DM2, GDM (postprandial glucose control)
Diabetes Drugs - What are the toxicities of the rapid acting Insulin drugs (Lispro, Aspart, Glulisine)?
Hypoglycemia, rare hypersensitivity reactions
Diabetes Drugs - What is the clinical use of the short acting Insulin drugs (Regular)?
DM1, DM2, GDM, DKA (IV), hyperkalemia (+ glucose), stress hyperglycemia
Diabetes Drugs - What is the clinical use of the intermediate acting Insulin drugs (NPH)?
DM1, DM2, GDM
Diabetes Drugs - What is the clinical use of the long acting Insulin drugs (Glargine, Detemir)?
DM1, DM2, GDM (basal glucose control)
Diabetes Drugs - What is the mechanism of Biguanides (Metformin)?
Exact mechanism is unknown. ↓ gluconeogenesis, ↑ glycolysis, ↑ peripheral glucose uptake (insulin sensitivity).
Diabetes Drugs - What is the clinical use of Biguanides (Metformin)?
Oral. First-line therapy in type 2 DM.
Can be used in patients without islet function.
Diabetes Drugs - What are the toxicities of Biguanides (Metformin)?
GI upset; most serious adverse effect is lactic acidosis (thus contraindicated in renal failure)
Diabetes Drugs - What is the mechanism of Sulfonylureas (First generation: Tolbutamide, Chlorpropamide; Second generation: Glyburide, Glimepiride, Glipizide)?
Close K+ channel in β-cell membrane, so cell depolarizes → triggering of insulin release via ↑ Ca2+ influx
Diabetes Drugs - What is the clinical use of Sulfonylureas (First generation: Tolbutamide, Chlorpropamide; Second generation: Glyburide, Glimepiride, Glipizide)?
Stimulate release of endogenous insulin in type 2 DM. Require some islet function, so useless in type 1 DM.
Diabetes Drugs - What are the toxicities of Sulfonylureas (First generation: Tolbutamide, Chlorpropamide; Second generation: Glyburide, Glimepiride, Glipizide)?
Risk of hypoglycemia ↑ in renal failure.
First generation: disulfiram-like effects.
Second generation: hypoglycemia.
Diabetes Drugs - What is the mechanism of Glitazones/thiazolidinediones (Pioglitazone, Rosiglitazone)?
↑ insulin sensitivity in peripheral tissue. Binds to PPAR-γ nuclear transcription regulator.
Genes activated by PPAR-γ regulate fatty acid storage and glucose metabolism. Activation of PPAR-γ ↑ insulin sensitivity and levels of adiponectin.
Diabetes Drugs - What is the clinical use of Glitazones/thiazolidinediones (Pioglitazone, Rosiglitazone)?
Used as monotherapy in type 2 DM or combined with above agents.
Diabetes Drugs - What are the toxicities of Glitazones/thiazolidinediones (Pioglitazone, Rosiglitazone)?
Weight gain, edema.
Hepatotoxicity, heart failure.
Diabetes Drugs - What is the mechanism of α-glucosidase inhibitors (Acarbose, Miglitol)?
Inhibit intestinal brush-border α-glucosidases.
Delayed sugar hydrolysis and glucose absorption → ↓ postprandial hyperglycemia.
Diabetes Drugs - What is the clinical use of α-glucosidase inhibitors (Acarbose, Miglitol)?
Used as monotherapy in type 2 DM or in combination with above agents.
Diabetes Drugs - What are the toxicities of α-glucosidase inhibitors (Acarbose, Miglitol)?
GI disturbances
Diabetes Drugs - What is the mechanism of Amylin analogs (Pramlintide)?
↓ gastric emptying, ↓ glucagon
Diabetes Drugs - What is the clinical use of Amylin analogs (Pramlintide)?
Type 1 and type 2 DM
Diabetes Drugs - What are the toxicities of Amylin analogs (Pramlintide)?
Hypoglycemia, nausea, diarrhea
Diabetes Drugs - What is the mechanism of GLP-1 analogs (Exenatide, Liraglutide)?
↑ insulin, ↓ glucagon release.
Diabetes Drugs - What is the clinical use of GLP-1 analogs (Exenatide, Liraglutide)?
Type 2 DM
Diabetes Drugs - What are the toxicities of GLP-1 analogs (Exenatide, Liraglutide)?
Nausea, vomiting; pancreatitis
Diabetes Drugs - What is the mechanism of DPP-4 inhibitors (Linagliptin, Saxagliptin, Sitagliptin)?
↑ insulin, ↓ glucagon release.
Diabetes Drugs - What is the clinical use of DPP-4 inhibitors (Linagliptin, Saxagliptin, Sitagliptin)?
Type 2 DM